When hyperphosphatemia occurred in the HD patients, the serum FGF-23 level elevated, 1,25(OH)2D3 level decreased, and renin-angiotensin-aldosterone system activation, all may deteriorate the systemic inflammation. The gene discussed is REN; the disease is hyperphosphatemia.